Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P84095
UPID:
RHOG_HUMAN
Alternative names:
-
Alternative UPACC:
P84095; P35238; Q8NI04
Background:
Rho-related GTP-binding protein RhoG plays a pivotal role in various cellular processes, including actin cytoskeleton reorganization, cell migration, and membrane trafficking. It is essential for immunological synapse formation, facilitating F-actin density and architecture organization. RhoG's activation modulates Rac1 activity, crucial for lymphocyte function, and supports macropinocytosis by forming membrane ruffles. Additionally, it is involved in leukocyte trans-endothelial migration and binds phospholipids for protein anchoring to the plasma membrane. RhoG also contributes to lymphocyte cytotoxicity by promoting exocytosis of cytotoxic granules.
Therapeutic significance:
Understanding the role of Rho-related GTP-binding protein RhoG could open doors to potential therapeutic strategies.